Publications by authors named "Ja-An Lin"

Claim this Profile
A
Assessing readability and comprehension of informed consent materials for medical device research: A survey of informed consents from FDA's Center for Devices and Radiological Health.
Fabienne Santel, Isatu Bah, Katherine Kim, Ja-An Lin, Jack McCracken

Contemp Clin Trials· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development.
Yun-Chieh Sung, Ya-Chi Liu, Po-Han Chao, Chih-Chun Chang, Pei-Ru Jin, Ts-Ting Lin, Ja-An Lin, Ling-Hsuan Chen

Theranostics· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Benchmark Concentration (BMC) Analysis on Zebrafish Data: A New Perspective for Quantifying Toxicity in Alternative Animal Models.
Jui-Hua Hsieh, Kristen Ryan, Alexander Sedykh, Ja-An Lin, Andrew J Shapiro

Toxicol Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-Specific Outcomes After Transcatheter Aortic Valve Replacement: FDA Patient-Level Meta-Analysis of Premarket Clinical Trials.
Robbert Zusterzeel, Nishant K Mishra, Hind Beydoun, John Laschinger, Changfu Wu, Ja-An Lin

J Womens Health (Larchmt)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-time cell toxicity profiling of Tox21 10K compounds reveals cytotoxicity dependent toxicity pathway linkage.
Jui-Hua Hsieh, Ruili Huang, Ja-An Lin, Alexander Sedykh, Jinghua Zhao

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Real-time cell toxicity profiling of Tox21 10K compounds reveals cytotoxicity dependent toxicity pathway linkage.
Jui-Hua Hsieh, Ruili Huang, Ja-An Lin, Alexander Sedykh, Jinghua Zhao

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies.
Ja-An Lin, Pei He

Br Med Bull· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
Jacquelyn Coloe Dosal, Paul W Stewart, Ja-An Lin, Christianna S Williams, Dean S Morrell

Pediatr Dermatol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional-mixed effects models for candidate genetic mapping in imaging genetic studies.
Ja-An Lin, Hongtu Zhu, Ahn Mihye, Wei Sun, Joseph G Ibrahim

Genet Epidemiol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projection regression models for multivariate imaging phenotype.
Ja-an Lin, Hongtu Zhu, Rebecca Knickmeyer, Martin Styner, John Gilmore

Genet Epidemiol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI.
Martha Skup, Hongtu Zhu, Yaping Wang, Kelly S Giovanello, Ja-an Lin, Weili Lin

Neuroimage· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis